COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods

Florian B. Mayr, Victor B. Talisa, Alexander D. Castro, Obaid S. Shaikh, Saad B. Omer, Adeel A. Butt

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

The SARS-CoV-2 Omicron variant is thought to cause less severe disease among the general population, but disease severity among at-risk populations is unknown. We performed a retrospective analysis using a matched cohort of United States veterans to compare the disease severity of subjects infected during Omicron and Delta predominant periods within 14 days of initial diagnosis. We identified 22,841 matched pairs for both periods. During the Omicron period, 20,681 (90.5%) veterans had mild, 1308 (5.7%) moderate, and 852 (3.7%) severe disease. During the Delta predominant period, 19,356 (84.7%) had mild, 1467 (6.4%) moderate, and 2018 (8.8%) severe disease. Moderate or severe disease was less likely during the Omicron period and more common among older subjects and those with more comorbidities. Here we show that infection with the Omicron variant is associated with less severe disease than the Delta variant in a high-risk older veteran population, and vaccinations provide protection against severe or critical disease.

Original languageEnglish (US)
Article number3647
JournalNature communications
Volume13
Issue number1
DOIs
StatePublished - Dec 2022
Externally publishedYes

ASJC Scopus subject areas

  • General Chemistry
  • General Biochemistry, Genetics and Molecular Biology
  • General
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods'. Together they form a unique fingerprint.

Cite this